FITZGERALD MEGHAN sold 18.9% of their position (10K shares) of ROIVANT SCIENCES LTD. on the open market
Open‑market sale worth $349.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/2/2026ACC: 0001349297-26-000004
-10K
Net shares
Net seller
$349.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+10K
Price / share
$8.80
Trade value
$88K
% of position
23.3%
6/30/2026
42.96K→52.96K
Common Shares
Direct
Shares
−10K
Price / share
$34.90
Trade value
$349K
% of position
18.9%
6/30/2026
52.96K→42.96K
Total
Net shares
+0.00
Net value
-$261K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 6/30/2026 | M · Option Exercise | +10K | $8.80 | $88K | 23.3% | 42.96K | 52.96K |
| Common Shares Direct | 6/30/2026 | S · Sale | −10K | $34.90 | $349K | 18.9% | 52.96K | 42.96K |
| Total | +0.00 | -$261K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
8.80
Held after
38.58K
Exercisable
—
6/30/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock10K shares | 6/30/2026 | M · Option Exercise | −10K | 8.80 | — | 38.58K |